Clinical, immunophenotypic and functional characterisation of T-cell leukaemia in six horses.

The research article discusses the clinical, immunophenotypic, and functional characteristics of T-cell leukaemia in six horses, aiming to improve the understanding and classification of equine Lymphoid leukaemia (LL).

Research Methods

• Analysis of clinical records and pathological findings from six cases of equine LL was conducted to document the variations in clinical course and presenting signs.
• Immunohistochemistry, a process that uses antibodies to check for certain antigens in a sample of tissue, was utilized on paraffin-embedded tissues in four cases to identify T or B lymphocytes, which are types of white blood cells.
• Peripheral blood mononuclear cells (PBMC), which are cells in the blood that have round nuclei, were phenotyped for the expression of CD4, CD8, MHC class I and II, and B-cell antigens in four cases using monoclonal antibodies and flow cytometry, methods used to measure the physical and chemical characteristics of a sample of cells.
• Lymphocytes, a type of white blood cell, from the horses were stimulated with mitogens, substances that encourage a cell to commence cell division, triggering mitosis. This was to test the functionality of the neoplastic lymphocytes, the cells that cause leukaemia.

Research Findings

• Six horses of different breeds were identified with LL of T-cell origin presenting varied clinical courses and signs.
• All horses exhibited neoplastic lymphocytes in their peripheral blood samples, and tissue invasion was confirmed post-mortem in four of the horses.
• Immunophenotyping revealed a predominance of CD3+ T-cells in lymphoid tissues and CD4+ T-cells in circulating peripheral blood mononuclear cells (PBMC) in the affected horses, indicating an alteration in the immune response of the victims.
• The neoplastic lymphocytes from the four tested cases failed to proliferate in response to mitogens, implying a mitigated functionality in the diseased cells.

Conclusions

• This research provides a more detailed characterisation of the clinical, pathological, and immunological findings in T-cell leukaemia affected horses, enriching the existing knowledge base of this rare condition.
• These insights generate a foundation for further investigations into this form of equine leukaemia, offering potential advancements towards defining distinct leukaemic types (similar to human classification) and developing more targeted treatment strategies for equine LL.